BioAge Labs’ novel obesity treatment could boost the biotechnology company’s stock, the Wall Street bank says.
A potential ‘home run’ trade is emerging in this pharma stock
Tony Zhang breaks down how to trade this stock using options.
Deutsche Bank initiates AppLovin at buy rating, sees growth within ‘best in class’ e-commerce advertising
Deutsche Bank sees shares of AppLovin rising 28% from here.
Here are Wednesday’s biggest analyst calls: Apple, Amazon, Netflix, Deere, Dell, 3M, AppLovin, Block
Here are Wednesday’s biggest calls on Wall Street.
RBC says buy this tractor maker as it leads push towards tech-enabled agriculture
The bank initiated shares of the construction machinery manufacturer at an outperform rating.
Netflix delivered a third-quarter earnings miss. Here’s how analysts reacted
Wall Street analysts remained largely split between adopting a neutral or optimistic stance on Netflix going forward.
Goldman Sachs highlights ‘buyback aristocrats’ in hunt for future outperformers
An equal-weight portfolio of so-called buyback aristocrats has outperformed the equal-weight S&P 500 so far this year, Goldman says. Here are names on the list.
Morgan Stanley’s top picks for the rest of earnings season
These stocks are likely to appreciate as the third-quarter earnings season ramps up, according to Morgan Stanley.
Palantir has been sitting out this latest leg of the bull run. What the charts say happen next
Palantir has been eerily quiet since the August sell-off.
Gold is getting knocked on Tuesday – it’s still the hottest trade of the year
There’s another corner of the market that Wall Street is enthusiastic about.